Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP222837.RARB03sl2XQuprCmto1QJWgT1ieWOJ3GeZ-emrpkh68Jk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP222837.RARB03sl2XQuprCmto1QJWgT1ieWOJ3GeZ-emrpkh68Jk130_assertion type Assertion NP222837.RARB03sl2XQuprCmto1QJWgT1ieWOJ3GeZ-emrpkh68Jk130_head.
- NP222837.RARB03sl2XQuprCmto1QJWgT1ieWOJ3GeZ-emrpkh68Jk130_assertion description "[Results from this investigation suggest that the ADAM10 rs514049-rs653765 C-A promoter haplotype is associated with: (1) higher CSF sAPP? levels in cognitively normal controls compared with Alzheimer's disease (AD) patients, (2) higher postmortem brain hippocampus, but not cerebellum, ADAM10 protein levels in subjects with low plaque scores compared with those with high plaque scores, and (3) higher promoter activity for promoter-only reporter constructs compared with promoter 3' untranslated region (3'UTR) constructs in the human neuroblastoma SHSY5Y cell line, but not in HepG2 or U118 cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP222837.RARB03sl2XQuprCmto1QJWgT1ieWOJ3GeZ-emrpkh68Jk130_provenance.
- NP222837.RARB03sl2XQuprCmto1QJWgT1ieWOJ3GeZ-emrpkh68Jk130_assertion evidence source_evidence_literature NP222837.RARB03sl2XQuprCmto1QJWgT1ieWOJ3GeZ-emrpkh68Jk130_provenance.
- NP222837.RARB03sl2XQuprCmto1QJWgT1ieWOJ3GeZ-emrpkh68Jk130_assertion SIO_000772 22572541 NP222837.RARB03sl2XQuprCmto1QJWgT1ieWOJ3GeZ-emrpkh68Jk130_provenance.
- NP222837.RARB03sl2XQuprCmto1QJWgT1ieWOJ3GeZ-emrpkh68Jk130_assertion wasDerivedFrom befree-20150227 NP222837.RARB03sl2XQuprCmto1QJWgT1ieWOJ3GeZ-emrpkh68Jk130_provenance.
- NP222837.RARB03sl2XQuprCmto1QJWgT1ieWOJ3GeZ-emrpkh68Jk130_assertion wasGeneratedBy ECO_0000203 NP222837.RARB03sl2XQuprCmto1QJWgT1ieWOJ3GeZ-emrpkh68Jk130_provenance.